Virtual Tour
Media
NEWS
Contact Us
Patients
Neurology & Ophthalmology
CinnoVex
ReciGen
CinnoTec
Xacrel
TYALIa
Cinnomer
Oncology & Hematology
PegaGen
CinnaPoietin
ZakAria
Ablyze
CinnaStim
Pectuna
Xtramab
KidiPeg
Endocrinology & infertility
Cinnal-f
CinnaFact
CinnaTropin
Melitide
CinnoPar
Maciza
Herozyme
Lixafert
Autoimmune & Immunology & Enzymes
Zerafil
SpikoGen
Eldixia
CinnoRA
Healthcare Professionals
Neurology & Ophthalmology
CinnoVex
ReciGen
Cinnomer
Xacrel
TYALIa
CinnoTec
Oncology & Hematology
PegaGen
CinnaPoietin
KidiPeg
ZakAria
Ablyze
CinnaStim
Pectuna
Endocrinology & infertility
Cinnal-f
CinnaTropin
Herozyme
CinnaFact
CinnoPar
Lixafert
Melitide
Autoimmune & Immunology
CinnoRA
Zerafil
SpikoGen
Capabilities
Our Technology
Business Development
Our Manufacturing Sites
Research and Development
About Us
Presidential Note
About CinnaGen
Mission Statement
Policy
Management Team
Search
Virtual Tour
Media
NEWS
Contact Us
Jan2019 / PR /
Previuos News
CinnaGen Sponsors IranPharma Expo
Next News
CinnaGen ilac has been established in 2019
tags:
CinnaGen
More in this category:
Eldixia®
Xtramab®
Herozyme®
Lixafert
Launching the Iranian medicine "CinnoRA", in the presence of Minister of Health
26Oct 2016
Razi Research Festival on Medical Sciences
17Jan 2017
CinnaGen ilaç
20Jan 2017
CinnaGen obtained a Halal Certificate
30May 2018
CinnaGen Sponsors IranPharma Expo
23Sept. 2018
CinnaGen obtained GMP certification from EMA
24Feb. 2018
CinnaGen in Iraq Health care Exhibition
28June 2018
Cinnagen in Duphat
03Mar. 2018
Researchers announced safety and effectiveness of ReciGen (interferon beta-1a 44 mcg manufactured by CinnaGen Co.) on COVID-19 patients
20June 2020
Reports of unauthorized export and availability of counterfeit products of CinnaGen
15May 2022
Home
Happy New Year
Back top Top